Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1447239231
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
3805 E Bell Rd Ste 2400
Phoenix, AZ, 85032
Phone (602) 482-2116
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
1,243 services
Medicare patients, 2024
14
Average age 64
Drug cost, 2024
$4.4M
1,495 prescriptions
Company payments, 2025
$284K
From 23 companies
Medicare prescription drug claims, 2024
In 2024, the drug Barry A Hendin prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 173 prescriptions and refills. In total Barry A Hendin wrote 1,495 Medicare prescriptions that cost $4.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-20.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Dalfampridine Er Dalfampridine | 173 | 213 | 35 | $56K |
| Baclofen Generic | 163 | 379 | 44 | $4,419 |
| Gabapentin Generic | 89 | 197 | 22 | $2,235 |
| Kesimpta Pen Ofatumumab | 87 | 89 | 12 | $804K |
| Escitalopram Oxalate Generic | 60 | 117 | 13 | $671 |
| Tizanidine Hcl Generic | 58 | 118 | 17 | $951 |
| Modafinil Generic | 50 | 96 | 15 | $6,077 |
| Amitriptyline Hcl Generic | 49 | 101 | 19 | $915 |
| Pregabalin Generic | 45 | 69 | Under 11 | $1,268 |
| Levetiracetam Generic | 41 | 96 | Under 11 | $2,380 |
| Vumerity Diroximel Fumarate | 38 | 38 | Under 11 | $330K |
| Duloxetine Hcl Generic | 34 | 50 | Under 11 | $580 |
| Clonazepam Generic | 28 | 38 | Under 11 | $214 |
| Diazepam Generic | 28 | 30 | Under 11 | $125 |
| Glatiramer Acetate Generic | 24 | 24 | Under 11 | $35K |
Brand drugs: - claims; generic drugs: 1,142 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barry A Hendin $284K ($280K in general payments such as food, travel and fees and $4,434 for research) from 23 companies. The largest payer was EMD Serono, Inc. with $104K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 68 | $104K |
| Biogen, Inc. BIIB | 67 | $41K |
| Novartis Pharmaceuticals Corporation NVS | 51 | $34K |
| Alexion Pharmaceuticals, Inc. AZN | 25 | $24K |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $24K |
| TG Therapeutics, Inc. TGTX | 37 | $17K |
| Amgen Inc. AMGN | 27 | $13K |
| Genentech USA, Inc. ROG.SW | 21 | $13K |
| Genzyme Corporation SNY | 10 | $5,617 |
| Vanda Pharmaceuticals Inc. VNDA | 13 | $4,378 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.